280 related articles for article (PubMed ID: 7863328)
21. Increased expression of the P27KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1.
Doki Y; Imoto M; Han EK; Sgambato A; Weinstein IB
Carcinogenesis; 1997 Jun; 18(6):1139-48. PubMed ID: 9214595
[TBL] [Abstract][Full Text] [Related]
22. Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts.
Kitzmann M; Fernandez A
Cell Mol Life Sci; 2001 Apr; 58(4):571-9. PubMed ID: 11361092
[TBL] [Abstract][Full Text] [Related]
23. Intestinal cell cycle regulations. Interactions of cyclin D1, Cdk4, and p21Cip1.
Beauchamp RD; Sheng HM; Shao JY; Thompson EA; Ko TC
Ann Surg; 1996 May; 223(5):620-7; discussion 627-8. PubMed ID: 8651753
[TBL] [Abstract][Full Text] [Related]
24. Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RD.
Knudsen ES; Pazzagli C; Born TL; Bertolaet BL; Knudsen KE; Arden KC; Henry RR; Feramisco JR
Cancer Res; 1998 May; 58(9):2042-9. PubMed ID: 9581851
[TBL] [Abstract][Full Text] [Related]
25. Modulation of acto-myosin contractility in skeletal muscle myoblasts uncouples growth arrest from differentiation.
Dhawan J; Helfman DM
J Cell Sci; 2004 Aug; 117(Pt 17):3735-48. PubMed ID: 15252113
[TBL] [Abstract][Full Text] [Related]
26. Chemical transformation of mouse liver cells results in altered cyclin D-CDK protein complexes.
Gonzales AJ; Goldsworthy TL; Fox TR
Carcinogenesis; 1998 Jun; 19(6):1093-102. PubMed ID: 9667749
[TBL] [Abstract][Full Text] [Related]
27. Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21.
Musgrove EA; Lee CS; Cornish AL; Swarbrick A; Sutherland RL
Mol Endocrinol; 1997 Jan; 11(1):54-66. PubMed ID: 8994188
[TBL] [Abstract][Full Text] [Related]
28. cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity.
Kitzmann M; Vandromme M; Schaeffer V; Carnac G; Labbé JC; Lamb N; Fernandez A
Mol Cell Biol; 1999 Apr; 19(4):3167-76. PubMed ID: 10082583
[TBL] [Abstract][Full Text] [Related]
29. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
Mann DJ; Higgins T; Jones NC; Rozengurt E
Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
[TBL] [Abstract][Full Text] [Related]
30. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein.
Zhu X; Ohtsubo M; Böhmer RM; Roberts JM; Assoian RK
J Cell Biol; 1996 Apr; 133(2):391-403. PubMed ID: 8609171
[TBL] [Abstract][Full Text] [Related]
31. Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts.
L'Allemain G; Lavoie JN; Rivard N; Baldin V; Pouyssegur J
Oncogene; 1997 Apr; 14(16):1981-90. PubMed ID: 9150365
[TBL] [Abstract][Full Text] [Related]
32. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes.
Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E
J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032
[TBL] [Abstract][Full Text] [Related]
33. Cyclin E-cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cells.
Tintignac LA; Leibovitch MP; Kitzmann M; Fernandez A; Ducommun B; Meijer L; Leibovitch SA
Exp Cell Res; 2000 Aug; 259(1):300-7. PubMed ID: 10942602
[TBL] [Abstract][Full Text] [Related]
34. Uncoupling of p21 induction and MyoD activation results in the failure of irreversible cell cycle arrest in doxorubicin-treated myocytes.
Puri PL; Medaglia S; Cimino L; Maselli C; Germani A; De Marzio E; Levrero M; Balsano C
J Cell Biochem; 1997 Jul; 66(1):27-36. PubMed ID: 9215525
[TBL] [Abstract][Full Text] [Related]
35. Induction of growth arrest and cell death by overexpression of the cyclin-Cdk inhibitor p21 in hamster BHK21 cells.
Sekiguchi T; Hunter T
Oncogene; 1998 Jan; 16(3):369-80. PubMed ID: 9467962
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide examination of myoblast cell cycle withdrawal during differentiation.
Shen X; Collier JM; Hlaing M; Zhang L; Delshad EH; Bristow J; Bernstein HS
Dev Dyn; 2003 Jan; 226(1):128-38. PubMed ID: 12508234
[TBL] [Abstract][Full Text] [Related]
37. Activation of MyoD-dependent transcription by cdk9/cyclin T2.
Simone C; Stiegler P; Bagella L; Pucci B; Bellan C; De Falco G; De Luca A; Guanti G; Puri PL; Giordano A
Oncogene; 2002 Jun; 21(26):4137-48. PubMed ID: 12037670
[TBL] [Abstract][Full Text] [Related]
38. Cyclin E, a redundant cyclin in breast cancer.
Gray-Bablin J; Zalvide J; Fox MP; Knickerbocker CJ; DeCaprio JA; Keyomarsi K
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15215-20. PubMed ID: 8986790
[TBL] [Abstract][Full Text] [Related]
39. Cyclin D3 promotes myogenic differentiation and Pax7 transcription.
Gurung R; Parnaik VK
J Cell Biochem; 2012 Jan; 113(1):209-19. PubMed ID: 21898542
[TBL] [Abstract][Full Text] [Related]
40. [Interactions of proliferation and differentiation signaling pathways in myogenesis].
Milewska M; Grabiec K; Grzelkowska-Kowalczyk K
Postepy Hig Med Dosw (Online); 2014 May; 68():516-26. PubMed ID: 24864103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
